{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:48:36Z","timestamp":1787644116275,"version":"build-2736575974"},"reference-count":46,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Stop Cancer Foundation, Concern Foundation and Markel Friedman Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis and an established therapeutic target in diseases such as cancer and ocular disorders. However, long-term use of most current anti-VEGF agents is often limited by their associated side effects, including hypertension, bleeding, and gastrointestinal complications. These limitations have stimulated interest in naturally occurring VEGF inhibitors derived from dietary sources, which may offer safer alternatives due to their favorable safety profiles. In this study, we investigated shared structural features of potent VEGFR2 inhibitors, focusing on naturally derived polyphenols. Polyphenols representing multiple structural subclasses were evaluated for their ability to inhibit VEGFR2 kinase activity using an in vitro kinase assay, to suppress VEGF-induced phosphorylation of VEGFR2 and downstream MAPK signaling in endothelial cells by Western blot, and to reduce VEGF-stimulated endothelial cell proliferation. Across all assays, flavonoids with strong VEGFR2 inhibitory activity displayed consistent structural characteristics, including the number and specific positioning of hydroxyl groups on the A- and B-rings, as well as specific structural elements of the C-ring. Our findings provide a strong foundation for further structure\u2013activity relationship (SAR) studies and facilitate identification of key molecular determinants required for VEGFR2 inhibition. Elucidation of these structural patterns may contribute to the development of more effective and safer angiogenesis inhibitors with reduced adverse effects.<\/jats:p>","DOI":"10.3390\/ijms27083605","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:24:23Z","timestamp":1776673463000},"page":"3605","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Flavonoids as Inhibitors of VEGFR2 Signaling: Structural Insights for the Development of Safer Anti-Angiogenic Therapies"],"prefix":"10.3390","volume":"27","author":[{"given":"Andrew","family":"Yim","sequence":"first","affiliation":[{"name":"Department of Surgery, City of Hope National Medical Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Surgery, City of Hope National Medical Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Surgery, City of Hope National Medical Center, Duarte, CA 91010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41573-023-00671-z","article-title":"Targeting angiogenesis in oncology, ophthalmology and beyond","volume":"22","author":"Cao","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in Signaling and Disease: Beyond Discovery and Development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wang, L., Liu, W.-Q., Broussy, S., Han, B., and Fang, H. (2024). Recent advances of anti-angiogenic inhibitors targeting VEGF\/VEGFR axis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1307860"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0958-1669(00)00153-1","article-title":"VEGF: An update on biological and therapeutic aspects","volume":"11","author":"Ferrara","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.ejca.2006.09.015","article-title":"The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors; A review","volume":"42","author":"Eskens","year":"2006","journal-title":"Eur. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Matsuo, Y. (2023). Natural Products and Cancer. Nutrients, 15.","DOI":"10.3390\/nu15245064"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1481850","DOI":"10.3389\/fphar.2024.1481850","article-title":"Natural products: Promising therapeutics for targeting regulatory immune cells in the tumor microenvironment","volume":"15","author":"Song","year":"2024","journal-title":"Front. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: Advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"100167","DOI":"10.1016\/j.crphar.2023.100167","article-title":"Flavonoids as promising molecules in the cancer therapy: An insight","volume":"6","author":"Mir","year":"2024","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Farhan, M., Rizvi, A., Aatif, M., and Ahmad, A. (2023). Current Understanding of Flavonoids in Cancer Therapy and Prevention. Metabolites, 13.","DOI":"10.3390\/metabo13040481"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"de Luna, F.C.F., Ferreira, W.A.S., Casseb, S.M.M., and de Oliveira, E.H.C. (2023). Anticancer Potential of Flavonoids: An Overview with an Emphasis on Tangeretin. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091229"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zahra, M., Abrahamse, H., and George, B.P. (2024). Flavonoids: Antioxidant Powerhouses and Their Role in Nanomedicine. Antioxidants, 13.","DOI":"10.3390\/antiox13080922"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, M., Qian, M., Jiang, Q., Tan, B., Yin, Y., and Han, X. (2023). Evidence of Flavonoids on Disease Prevention. Antioxidants, 12.","DOI":"10.3390\/antiox12020527"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/bjc.2015.25","article-title":"Dietary intake of flavonoids and oesophageal and gastric cancer: Incidence and survival in the United States of America (USA)","volume":"112","author":"Petrick","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hui, C., Qi, X., Qianyong, Z., Xiaoli, P., Jundong, Z., and Mantian, M. (2013). Flavonoids, Flavonoid Subclasses and Breast Cancer Risk: A Meta-Analysis of Epidemiologic Studies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0054318"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"73573","DOI":"10.18632\/oncotarget.12017","article-title":"Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies","volume":"7","author":"Lei","year":"2016","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1753-4887.2012.00508.x","article-title":"Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations","volume":"70","author":"Peterson","year":"2012","journal-title":"Nutr. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0140-6736(93)92876-U","article-title":"Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study","volume":"342","author":"Hertog","year":"1993","journal-title":"Lancet"},{"key":"ref_22","first-page":"2309","article-title":"Epidemiological Evidences on Dietary Flavonoids and Breast Cancer Risk: A Narrative Review","volume":"18","author":"Sak","year":"2017","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12967-024-04949-7","article-title":"Association of dietary flavonoid intakes with prevalence of chronic respiratory diseases in adults","volume":"22","author":"Wu","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"100558","DOI":"10.1016\/j.phyplu.2024.100558","article-title":"Multi-therapeutic potential of flavonoids as an essential component in nutraceuticals for the treatment and management of human diseases","volume":"4","author":"Okoduwa","year":"2024","journal-title":"Phytomedicine Plus"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Li, R., Song, X., Guo, Y., Song, P., Duan, D., and Chen, Z.S. (2021). Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.772915"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1111\/bph.16232","article-title":"Natural products targeting tumour angiogenesis","volume":"182","author":"Lu","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/carcin\/bgp292","article-title":"Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling","volume":"31","author":"Lu","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Keravis, T., Favot, L., Abusnina, A.A., Anton, A., Justiniano, H., Soleti, R., Alabed Alibrahim, E., Simard, G., Andriantsitohaina, R., and Lugnier, C. (2015). Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0145291"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mirbabaei Ghafghazi, D., Kwan Sze, N.S., and Tsiani, E. (2026). Effects of Epigallocatechin Gallate Against Lung Cancer: Mechanisms of Action and Therapeutic Potential. Nutrients, 18.","DOI":"10.3390\/nu18030378"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/ar.24222","article-title":"Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF\/VEGFR2 and p38MAPK Signaling Pathways","volume":"302","author":"Zhou","year":"2019","journal-title":"Anat. Rec."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mnfr.201400478","article-title":"Potent inhibition of VEGFR-2 activation by tight binding of green tea epigallocatechin gallate and apple procyanidins to VEGF: Relevance to angiogenesis","volume":"59","author":"Moyle","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/1940-6207.CAPR-08-0040","article-title":"Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway","volume":"1","author":"Wen","year":"2008","journal-title":"Cancer Prev. Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wei, Q., and Zhang, Y.-h. (2024). Flavonoids with Anti-Angiogenesis Function in Cancer. Molecules, 29.","DOI":"10.3390\/molecules29071570"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2741\/229","article-title":"Dietary flavonoids as cancer-preventive and therapeutic biofactors","volume":"3","author":"Nishiumi","year":"2011","journal-title":"Front. Biosci. (Sch. Ed.)"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Khater, M., Greco, F., and Osborn, H.M.I. (2020). Antiangiogenic Activity of Flavonoids: A Systematic Review and Meta-Analysis. Molecules, 25.","DOI":"10.3390\/molecules25204712"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0955-2863(02)00204-8","article-title":"Antiangiogenic mechanisms of diet-derived polyphenols","volume":"13","author":"Cao","year":"2002","journal-title":"J. Nutr. Biochem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Bian, Y., Wei, J., Zhao, C., and Li, G. (2020). Natural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020684"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lin, S., Tang, R.W.-L., Ye, Y., Xia, C., Wu, J., Duan, R., Leung, K.-W., Dong, T.T.-X., and Tsim, K.W.-K. (2025). Drug Screening of Flavonoids as Potential VEGF Inhibitors Through Computational Docking and Cell Models. Molecules, 30.","DOI":"10.3390\/molecules30020257"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/mnfr.201500407","article-title":"Molecular structure-function relationship of dietary polyphenols for inhibiting VEGF-induced VEGFR-2 activity","volume":"59","author":"Cerezo","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hu, W.-H., Wang, H.-Y., Xia, Y.-T., Dai, D.K., Xiong, Q.-P., Dong, T.T.-X., Duan, R., Chan, G.K.-L., Qin, Q.-W., and Tsim, K.W.-K. (2020). Kaempferol, a Major Flavonoid in Ginkgo Folium, Potentiates Angiogenic Functions in Cultured Endothelial Cells by Binding to Vascular Endothelial Growth Factor. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00526"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1021\/acs.jmedchem.8b01593","article-title":"Inhibition of Inositol Polyphosphate Kinases by Quercetin and Related Flavonoids: A Structure-Activity Analysis","volume":"62","author":"Gu","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"105845","DOI":"10.1016\/j.jff.2023.105845","article-title":"Flavonoids as receptor tyrosine kinase inhibitors in lung cancer","volume":"110","author":"Farghadani","year":"2023","journal-title":"J. Funct. Foods"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Al-Khayri, J.M., Sahana, G.R., Nagella, P., Joseph, B.V., Alessa, F.M., and Al-Mssallem, M.Q. (2022). Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules, 27.","DOI":"10.3390\/molecules27092901"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Ginwala, R., Bhavsar, R., Chigbu, D.I., Jain, P., and Khan, Z.K. (2019). Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin. Antioxidants, 8.","DOI":"10.3390\/antiox8020035"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e13106","DOI":"10.1111\/sji.13106","article-title":"Immunomodulatory potential of flavonoids for the treatment of autoimmune diseases and tumour","volume":"95","author":"Han","year":"2022","journal-title":"Scand. J. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Hosseinzade, A., Sadeghi, O., Naghdipour Biregani, A., Soukhtehzari, S., Brandt, G.S., and Esmaillzadeh, A. (2019). Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00051"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3605\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:26:41Z","timestamp":1776673601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/8\/3605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["ijms27083605"],"URL":"https:\/\/doi.org\/10.3390\/ijms27083605","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]}}}